ReviewFrontiers in immunology2022

Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics.

Bhaswati Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.